(Q24235150)

English

Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

0 references

Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women (English)

0 references

0 references

premature ovarian failure

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hengxi Chen

1

0 references

Jinke Li

2

0 references

Tao Cui

3

0 references

Lina Hu

4

0 references

publication date

9 November 2011

0 references

Cochrane Database of Systematic Reviews

0 references

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Failure to preserve fertility in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Gonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Chemotherapy-induced premature ovarian failure: mechanisms and prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Early menopause in long-term survivors of cancer during adolescence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Fertility preservation and pregnancy outcome after malignancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

The effects of radiotherapy and chemotherapy on female reproduction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

The relationship of gonadal activity and chemotherapy-induced gonadal damage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

21 January 2018

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reproductive performance of female rats treated with cyclophosphamide and/or LHRH agonist

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide-Induced Ovarian Failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibin: a candidate gene for premature ovarian failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian antibodies, FSH and inhibin B: independent markers associated with unexplained infertility

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of menopause during the first year after breast cancer diagnosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008018.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD008018.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24235150&oldid=2104989957"